•Completers through Week 24 (n=672)
•
– n Mean (se) Treatment Effect (99.95% CI)
–MVC QD 283 137.8 (7.7) 41.1 (-5.0,87.3)
–MVC BID 296 123.6 (6.2) 26.9 (-18.9,66.3)
–Placebo 93
96.7 (10.8)
–
–
•LOCF through Week 24 (n=1033)
•
– n Mean (se) Treatment Effect (99.95% CI)
–MVC QD 408 113.5 (6.1) 58.8 (26.5,91.1)
–MVC BID 418 105.9 (5.1) 51.2 (21.0,81.4)
–Placebo 207 54.7 (7.0)
–
•Treatment effects are robust
–
•